COPERNIC: A study of on-treatment circulating tumour (ct) DNA changes in chemo-refractory colorectal cancer (CRC) patients

被引：0
|
作者：
Assaf, I. [1 ]
Bregni, G. [1 ]
Anthoine, G. [2 ]
Aparicio, T. [3 ]
Artru, P. [4 ]
Ben Abdelghani, M. [5 ]
Chibaudel, B. [6 ]
Coart, E. [7 ]
Diaz, M. [8 ]
Evrard, C. [9 ]
Geboes, K. [10 ]
Ghiringhelli, F. [11 ]
Puleo, F. [12 ]
Raimbourg, J. [13 ]
Vandamme, T. [14 ]
van den Eynde, M. [15 ]
Hendlisz, A. [1 ]
Sclafani, F. [1 ]
机构：
[1] Univ Libre Bruxelles ULB, Hop Univ Bruxelles HUB, Inst Jules Bordet, Dept Gastrointestinal Oncol, Anderlecht, Belgium
[2] Univ Libre Bruxelles ULB, Hop Univ Bruxelles HUB, Inst Jules Bordet, GI Lab, Anderlecht, Belgium
[3] Hop St Louis, AP HP, Dept Gastroenterol & Digest Oncol, Paris, France
[4] Hop Prive Jean Mermoz, Dept Gastrointestinal Oncol, Lyon, France
[5] ICANS Inst Cancerol Strasbourg Europe, Dept Oncol, Strasbourg, France
[6] Fdn Cognacq Jay, HFB Hop Franco Britann, Dept Med Oncol, Levallois Perret, France
[7] Int Inst Drug Dev, Biostat, Louvain, Belgium
[8] Hosp Ambroise Pare, Dept Oncol, Mons, Belgium
[9] CHU Poitiers Jean Bernard Hop, Dept Oncol, Poitiers, France
[10] UZ Gent, Dept Gastroenterol, Univ Hosp Ghent, Ghent, Belgium
[11] Ctr Georges Francois Leclerc Dijon, Dept Med Oncol, Dijon, France
[12] Chirec Delta, Dept Med Oncol, Auderghem, Belgium
[13] ICO Inst Cancerol Ouest Rene Gauducheau, Dept Med Oncol, St Herblain, France
[14] UZA Univ Hosp Antwerp, Dept Oncol, Edegem, Belgium
[15] UCLouvain St Luc, Dept Digest Oncol, Clin Univ St Luc, Woluwe St Lambert, Belgium
来源：
ANNALS OF ONCOLOGY | 2024年 / 35卷
关键词：
D O I：
10.1016/j.annonc.2024.05.169
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
159TiP
引用
收藏
页码：S70 / S71
页数：2
相关论文
共 50 条
  • [1] Rationale and Design of the COPERNIC Trial: A Study of On-treatment ctDNA Changes in Chemo-refractory Colorectal Cancer Patients
    Assaf, Irene
    Bregni, Giacomo
    Anthoine, Geraldine
    Aparicio, Thomas
    Artru, Pascal
    Ben Abdelghani, Meher
    Buyse, Marc
    Chibaudel, Benoist
    Coart, Elisabeth
    Diaz, Marie
    Evrard, Camille
    Geboes, Karen
    Ghiringhelli, Francois
    Puleo, Francesco
    Raimbourg, Judith
    Vandamme, Timon
    van den Eynde, Marc
    Hendlisz, Alain
    Sclafani, Francesco
    CLINICAL COLORECTAL CANCER, 2025, 24 (01) : 101 - 105
  • [2] Plasma circulating tumor DNA profiling in patients with chemo-refractory germ cell tumors
    Sakka, Shotaro
    Kandori, Shuya
    Kawai, Koji
    Kojima, Takahiro
    Nitta, Satoshi
    Chihara, Ichiro
    Nagumo, Yoshiyuki
    Kawahara, Takashi
    Mathis, Bryan J.
    Ishihara, Megumi
    Shinohara, Nobuo
    Kishida, Takeshi
    Ukimura, Osamu
    Nishimura, Kazuo
    Kobayashi, Yasuyuki
    Nishiyama, Hiroyuki
    INTERNATIONAL JOURNAL OF UROLOGY, 2023, 30 (05) : 456 - 462
  • [3] A RETROSPECTIVE ANALYSIS OF THE EFFICACY AND SAFETY OF REGORAFENIB IN PATIENTS WITH CHEMO-REFRACTORY COLORECTAL CANCER
    Oishi, Takayuki
    Takahashi, Masanobu
    Shiono, Masatoshi
    Takahashi, Shin
    Akiyama, Shoko
    Shirota, Hidekazu
    Shimodaira, Hideki
    Kato, Shunsuke
    Ishioka, Chikashi
    ANNALS OF ONCOLOGY, 2014, 25
  • [4] On-treatment measurements of circulating tumor DNA during FOLFOX therapy in patients with colorectal cancer
    Tina Moser
    Julie Waldispuehl-Geigl
    Jelena Belic
    Sabrina Weber
    Qing Zhou
    Samantha O. Hasenleithner
    Ricarda Graf
    Jasmin Alia Terzic
    Florian Posch
    Heinz Sill
    Sigurd Lax
    Karl Kashofer
    Gerald Hoefler
    Helmut Schoellnast
    Ellen Heitzer
    Jochen B. Geigl
    Thomas Bauernhofer
    Michael R. Speicher
    npj Precision Oncology, 4
  • [5] On-treatment measurements of circulating tumor DNA during FOLFOX therapy in patients with colorectal cancer
    Moser, Tina
    Waldispuehl-Geigl, Julie
    Belic, Jelena
    Weber, Sabrina
    Zhou, Qing
    Hasenleithner, Samantha O.
    Graf, Ricarda
    Terzic, Jasmin Alia
    Posch, Florian
    Sill, Heinz
    Lax, Sigurd
    Kashofer, Karl
    Hoefler, Gerald
    Schoellnast, Helmut
    Heitzer, Ellen
    Geigl, Jochen B.
    Bauernhofer, Thomas
    Speicher, Michael R.
    NPJ PRECISION ONCOLOGY, 2020, 4 (01)
  • [6] Uracil/tegafur as a possible salvage therapy in chemo-refractory colorectal cancer patients: a single institutional retrospective study
    Bayoglu, Ibrahim V.
    Yildiz, Ibrahim
    Varol, Umut
    Cokmert, Suna
    Alacacioglu, Ahmet
    Kucukzeybek, Yuksel
    Akyol, Murat
    Demir, Lutfiye
    Dirican, Ahmet
    Tarhan, Oktay
    WSPOLCZESNA ONKOLOGIA-CONTEMPORARY ONCOLOGY, 2015, 19 (05): : 385 - 390
  • [7] Editorial Comment to Plasma circulating tumor DNA profiling in patients with chemo-refractory germ cell tumors
    Yuasa, Takeshi
    INTERNATIONAL JOURNAL OF UROLOGY, 2023, 30 (05) : 463 - 463
  • [8] Clinical Value Of Apatinib As A Salvage Treatment In Patients With Chemo-Refractory Advanced Cervical Cancer
    Su, Meng
    Gao, Ya
    Ye, XuXue
    Zhou, QingYu
    Zhao, LiHao
    Cai, Xiaona
    Chen, Didi
    Su, Huafang
    Zhang, Xiaohua
    Xie, Congying
    ONCOTARGETS AND THERAPY, 2019, 12 : 9707 - 9713
  • [9] Initial experience of TAS-102 chemotherapy in Australian patients with Chemo-refractory metastatic colorectal cancer
    Jalali, A.
    Gard, G.
    Banks, S.
    Dunn, C.
    Wong, H. L.
    Wong, R.
    Lee, M.
    Gately, L.
    Loft, M.
    Shapiro, J. D.
    Kosmider, S.
    Tie, J.
    Ananda, S.
    Yeung, J. M.
    Jennens, R.
    Lee, B.
    McKendrick, J.
    Lim, L.
    Khattak, A.
    Gibbs, P.
    CURRENT PROBLEMS IN CANCER, 2022, 46 (02)
  • [10] Tumour naive circulating tumour DNA (ctDNA) analysis in patients (pts) with resected colorectal cancer (CRC) in the phase III ASCOLT trial
    Day, D.
    Starus, A.
    Lamik, A.
    Sieber, O.
    Begbie, S.
    Bonaventura, A.
    Rai, S.
    Karanth, N.
    Underhill, C. R.
    Nott, L. M.
    Van Hazel, G.
    Van Hagen, T.
    Wong, M.
    Saqib, A.
    Eastgate, M.
    Srivastav, R.
    Chia, J.
    Toh, H. C.
    Jones, F.
    Segelov, E.
    ANNALS OF ONCOLOGY, 2022, 33 (07) : S710 - S710
12345